Azilsartan Kamedoxomil
2 NDCs across 1 manufacturer|0 Generic,2 Brand
Azilsartan Kamedoxomil is used to treat hypertension, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Feb 25, 2011, and the first generic was approved Jul 20, 2022. FDA's Orange Book lists 4 AB-rated (therapeutically equivalent) products for this ingredient.
Azilsartan Kamedoxomil is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $8.28 to $9.00 per EA — a 9% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
0G / 2B
Manufacturers
1
competing in market
Price Spread
$8.28 – $9.00
per EA
7d Activity
avg -0.1% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing AZILSARTAN KAMEDOXOMIL
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
EDARBI 80 MG TABLET | $9.0042 per EA | -0.02% |
EDARBI 40 MG TABLET | $8.2828 per EA | -0.07% |
Frequently Asked Questions
What is Azilsartan Kamedoxomil used to treat?
Azilsartan Kamedoxomil is used to treat hypertension, per the National Library of Medicine's MED-RT classification.
When did Azilsartan Kamedoxomil become available as a generic?
FDA approved the first generic Azilsartan Kamedoxomil (ANDA) on Jul 20, 2022. The Orange Book currently lists 4 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How many Azilsartan Kamedoxomil products are on the market?
The Azilsartan Kamedoxomil drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.
What is the price range for Azilsartan Kamedoxomil?
NADAC reference prices for Azilsartan Kamedoxomil range from $8.2828 to $9.0042 per EA — a 9% difference between cheapest and most expensive.
Which manufacturers make Azilsartan Kamedoxomil?
1 manufacturer lists Azilsartan Kamedoxomil in NADAC. Ranked by number of NDCs, the largest are Azurity Pharmaceuticals Inc. (2).
How has the price of Azilsartan Kamedoxomil changed recently?
Over the past 7 days, 0 Azilsartan Kamedoxomil NDCs rose and 2 fell, with a market-wide average change of -0.1%.